About this trial

This trial evaluates the efficacy and safety of surfactant administration with thin catheter technique together with analgesic premedication in comparison with the established INSURE-strategy. It will provide valuable knowledge to improve clinical methodology and enhance lung protective treatment strategies for preterm infants.

Eligibility criteria

Qualifiers

Infants born before 32 completed weeks of gestation on CPAP, with clinical and radiological signs of RDS and need for surfactant treatment.

Disqualifiers

Infants requiring surfactant as part of delivery room resuscitation are not eligible.

Trial design

Treatments tested in this trial

  • Thin catheter technique or standard ET-tube for surfactant administration

Treatment groups

160 Participants
are divided into 2 treatment groups

Locations

1
Karolinska University Hospital14186, Stockholm Sweden

Sponsors and collaborators

Karolinska Institutet

Lead sponsor